Compounds > 2'-deoxyadenosine triphosphate
Page last updated: 2024-08-21

2'-deoxyadenosine triphosphate and Gonorrhea

2'-deoxyadenosine triphosphate has been researched along with Gonorrhea in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Arnold, M; Branstrom, A; Chen, G; Cui, C; Drennan, CL; Dumble, M; Gerasyuto, A; Hedrick, J; Jung, SP; Karp, G; Letinski, S; Levitz, T; Narasimhan, J; Ravichandran, K; Stubbe, J; Wang, J1

Other Studies

1 other study(ies) available for 2'-deoxyadenosine triphosphate and Gonorrhea

ArticleYear
Ribonucleotide reductase, a novel drug target for gonorrhea.
    eLife, 2022, 02-09, Volume: 11

    Topics: Allosteric Regulation; Animals; Anti-Bacterial Agents; Deoxyadenine Nucleotides; Disease Models, Animal; Drug Resistance, Bacterial; Escherichia coli; Female; Gonorrhea; Humans; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Pyridines; Ribonucleotide Reductases

2022